Several factors influence an individual's BAC, including body weight, gender, the rate of alcohol consumption, and the presence of food in the stomach
Routes Subcutaneous (SubQ) injection and topical formulations are the two main research-use routes
But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off
To treat patients with mild to moderate occlusive peripheral arterial disease, it is recommended that naftidrofuryl be administered orally at a dose of 300 to 600 mg/day in three divided sub-doses, swallowed whole
Hnilica reported that in aqueous solutions, the unfractionated calf-thymus histone and its four main fractions (F1, F2a, F2b and F3) were in the form of disordered chains (Jirgensons and Hnilica, 1965)